Pharmacological Challenge Model
Pharmacological Challenge Model - Related Videos
11:27
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
0 Views •
Cited by 9 •
2012
The goal of this technique is to assess serotonin (5-HT) neurotransmitter function in the live and free-breathing animal with pharmacological magnetic resonance imaging (phMRI) and an intravenous challenge with a selective serotonin reuptake inhibitor (SSRI), fluoxetine.
12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
0 Views •
Cited by 13 •
2013
Epidermal melanin is induced by topical application of forskolin in a murine model of the fair-skinned UV-sensitive human. Pharmacologic manipulation of cAMP levels in the skin and epidermal darkening strongly protect against UV-mediated inflammation (sunburn) as measured by the minimum erythematous dose (MED) assay.
07:48
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
0 Views •
Cited by 45 •
2016
Intravenous administration of endotoxin reliably elicits dose-dependent physiological and immunological alterations consistent with several pathological states. This reductionist approach permits the investigation, modeling and experimental modification of systemic inflammation and its downstream effects in man.
11:57
Organotypic Cerebellar Cultures: Apoptotic Challenges and Detection
0 Views •
Cited by 17 •
2011
This method describes the generation of organotypic cerebellar cultures and the effect of certain apoptotic stimuli on the viability of different cerebellar cell types.
01:20
Challenges in Global Marketing
0 Views •
2025
Global marketing is a complex field where businesses encounter a range of challenges as they expand into international markets. These challenges can stem from internal factors, such as strategic misalignment, communication breakdowns, and operational inefficiencies. Understanding and addressing these barriers is essential for companies aiming to establish a successful presence abroad. One of the primary obstacles is the development of non-country-specific marketing strategies. When businesses...
FAQs
Dose and timing determine the intensity and interpretability of the biological response. Investigators can vary the amount of challenge compound and the treatment schedule to examine how neural, physiological, or behavioral changes develop under different conditions. Comparing these responses helps characterize neurotransmitter systems and distinguish effects associated with particular exposure conditions.
A challenge compound can activate or inhibit selected receptors, transporters, or signaling pathways, allowing researchers to link a perturbation with measurable neural consequences. The resulting behavioral, physiological, or neural changes provide evidence about how a neurotransmitter system functions. This approach can also help clarify mechanisms of action relevant to normal function or dysfunction.
Controls provide the comparison needed to determine whether observed changes are associated with the challenge treatment rather than the experimental condition itself. When researchers compare treated and control groups across defined doses or timing conditions, they can evaluate the specificity and consistency of responses. This strengthens conclusions about neural mechanisms, drug effects, and possible adverse outcomes.
A study begins by selecting a challenge compound and defining the neural function or dysfunction to examine. Researchers then establish treatment conditions, including dose and timing, and identify appropriate controls. After administration, they measure behavioral, physiological, or neural responses. Comparing outcomes across conditions allows investigators to test the proposed mechanism and characterize the resulting effects.
Researchers may assess changes at behavioral, physiological, or neural levels, depending on the study question. These measurements can show how a compound affects brain-related function and whether responses vary with treatment conditions. Using multiple outcome types can help connect observable behavior or physiology with changes in neurotransmitter systems and signaling processes.
These models are useful when investigators need to examine drug efficacy, adverse effects, disease-related processes, or potential therapeutic strategies. By perturbing a relevant neural system and measuring its response, researchers can test mechanistic hypotheses about brain disorders. The findings may also support evaluation of targeted interventions and clarify how particular treatment conditions influence outcomes.